Now The End Begins – by Stephanie Buist
“My people are destroyed for lack of knowledge: because thou hast rejected knowledge, I will also reject thee, that thou shalt be no priest to me: seeing thou hast forgotten the law of thy God, I will also forget thy children.” Hosea 4:6
Just when we thought this nightmare couldn’t get any worse, now we find out that Monsanto has invested $1.5 Million in the Canadian pharmaceutical company for “specific development” of the agriculture RNAi project. The press release states:
The development milestone is part of the research program under the Option Agreement Tekmira signed with the agriculture company, which we announced on January 13, 2014. The Option Agreement relates to Tekmira’s proprietary delivery technology and intellectual property for use in agricultural applications. The potential value of the transaction could reach up to $86.2 million, following the successful completion of all program milestones.
Tekmira is the pharmaceutical company that has been working on the serum to treat Ebola. As I reported in my previous article on Ebola, the serum trial had been placed on hold while executives gathered information about how the drug works in the body per the request of the FDA.
Another press release about Tekmira reveals a $140 million contract with the U.S. military for Ebola treatment drugs:
TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed uner a $140 million contract from the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office.
In my previous article I reported that the TKM-Ebola project had been put on hold in July. However, now on August 7 , it has been reported that the FDA has placed the project on “partial hold”. This change in status will enable the potential use of the TKM-Ebola in cases where individuals have been infected with Ebola virus.
This is not the product that was given to the 2 doctors that are now residing at Emory University Hospital. They were given a different product called ZMapp from Kentucky BioProcessing . It was announced on August 7, 2014 that the FDA has lifted the hold on this experimental drug… CLICK HERE to read the rest of this story on Stepping Stones Living
Uh-oh. Here we go. Monsanto can’t make any money on this unless there is a serious outbreak, so it almost guaranteed.
The catalyst for the serum is tobacco, probably GMO tobacco. They
are relentless. Like Mandela said regarding the AIDS palliative tx,
he said the medications were giving people AIDS. So, who knows
with these scum.
Anything Monsanto involves itself in is sure to cause massive depopulation.